A Phase lIb, Randomized, Multicenter, Open-Label, Concentration-Controlled, Safety Study of ISA247 and Tacrolimus (Prograf) in De Novo Renal Transplant Patients

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/0612/31/09

Funding

  • Isotechnika Inc: $76,812.00